Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02365597
Title An Efficacy and Safety Study of JNJ-42756493 in Participants With Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | ROU | ISR | GBR | FRA | ESP | DEU | BEL | AUT


No variant requirements are available.